Fulgent Genetics, Inc. (FLGT)

USD 20.54

(19.07%)

Revenue Summary of Fulgent Genetics, Inc.

  • Fulgent Genetics, Inc.'s latest annual revenue in 2023 was 289.21 Million USD , down -53.27% from previous year.
  • Fulgent Genetics, Inc.'s latest quarterly revenue in 2024 Q2 was 71.02 Million USD , up 10.15% from previous quarter.
  • Fulgent Genetics, Inc. reported a annual revenue of 618.96 Million USD in annual revenue 2022, down -37.64% from previous year.
  • Fulgent Genetics, Inc. reported a annual revenue of 992.58 Million USD in annual revenue 2021, up 135.37% from previous year.
  • Fulgent Genetics, Inc. reported a quarterly revenue of 71.02 Million USD for 2024 Q2, up 10.15% from previous quarter.
  • Fulgent Genetics, Inc. reported a quarterly revenue of 66.16 Million USD for 2023 Q1, down -2.27% from previous quarter.

Annual Revenue Chart of Fulgent Genetics, Inc. (2023 - 2001)

Historical Annual Revenue of Fulgent Genetics, Inc. (2023 - 2001)

Year Revenue Revenue Growth
2023 289.21 Million USD -53.27%
2022 618.96 Million USD -37.64%
2021 992.58 Million USD 135.37%
2020 421.71 Million USD 1196.46%
2019 32.52 Million USD 52.31%
2018 21.35 Million USD 14.03%
2017 18.73 Million USD 2.48%
2016 18.27 Million USD 90.85%
2015 9.57 Million USD 649.3%
2014 1.27 Million USD 0.0%
2001 - USD 0.0%

Peer Revenue Comparison of Fulgent Genetics, Inc.

Name Revenue Revenue Difference
Aclaris Therapeutics, Inc. 31.24 Million USD -825.511%
Applied DNA Sciences, Inc. 13.36 Million USD -2063.563%
Aspira Women's Health Inc. 9.15 Million USD -3059.417%
Biodesix, Inc. 49.08 Million USD -489.185%
BioNexus Gene Lab Corp. 9.77 Million USD -2859.971%
bioAffinity Technologies, Inc. 2.53 Million USD -11320.064%
bioAffinity Technologies, Inc. 2.53 Million USD -11320.064%
Bionano Genomics, Inc. 36.11 Million USD -700.789%
CareDx, Inc 280.32 Million USD -3.171%
Check-Cap Ltd. - USD -Infinity%
Castle Biosciences, Inc. 219.78 Million USD -31.587%
DarioHealth Corp. 20.35 Million USD -1321.054%
Exact Sciences Corporation 2.49 Billion USD 88.43%
Guardant Health, Inc. 563.94 Million USD 48.716%
ICON Public Limited Company 8.12 Billion USD 96.438%
IDEXX Laboratories, Inc. 3.66 Billion USD 92.1%
Illumina, Inc. 4.5 Billion USD 93.579%
Intelligent Bio Solutions Inc. 3.11 Million USD -9194.131%
iSpecimen Inc. 9.92 Million USD -2813.05%
Standard BioTools Inc. 106.34 Million USD -171.97%
MDxHealth SA 70.19 Million USD -312.025%
23andMe Holding Co. 219.63 Million USD -31.677%
Medpace Holdings, Inc. 1.88 Billion USD 84.664%
Myriad Genetics, Inc. 678.4 Million USD 57.368%
Mainz Biomed B.V. 895.47 Thousand USD -32197.016%
ENDRA Life Sciences Inc. - USD -Infinity%
NeoGenomics, Inc. 591.64 Million USD 51.117%
Neogen Corporation 924.22 Million USD 68.707%
Inotiv, Inc. 572.42 Million USD 49.476%
Natera, Inc. 1.08 Billion USD 73.285%
OPKO Health, Inc. 863.49 Million USD 66.507%
Psychemedics Corporation 22.09 Million USD -1208.775%
Prenetics Global Limited 21.74 Million USD -1230.163%
Prenetics Global Limited 21.74 Million USD -1230.163%
Precipio, Inc. 15.19 Million USD -1803.093%
Personalis, Inc. 73.48 Million USD -293.589%
RadNet, Inc. 1.61 Billion USD 82.11%
Sera Prognostics, Inc. 306 Thousand USD -94414.052%
Sotera Health Company 1.04 Billion USD 72.437%
Neuronetics, Inc. 71.34 Million USD -305.355%
Star Equity Holdings, Inc. 45.78 Million USD -531.676%
Star Equity Holdings, Inc. 45.78 Million USD -531.676%
Trinity Biotech plc 56.83 Million USD -408.891%
Twist Bioscience Corporation 312.97 Million USD 7.592%
Exagen Inc. 52.54 Million USD -450.379%